A new trading day began on Tuesday, with Encompass Health Corp (NYSE: EHC) stock price up 3.00% from the previous day of trading, before settling in for the closing price of $96.12. EHC’s price has ranged from $79.25 to $104.55 over the past 52 weeks.
Here's Your FREE Report on the #1 Small-Cap Uranium Stock of '24.
Small-cap Uranium stocks are booming in 2024! The company we're about to show you is the ONLY small-cap stock in the space that benefits from ALL aspects of the global Uranium industry with none of the risks of running a mine. Smart investors will not be hesitating on this one!
Get the FREE Report with all the details here.
Sponsored
During the last 5-year period, the sales growth of Healthcare Sector giant was 3.59%. Meanwhile, its annual earnings per share averaged 8.53%. With a float of $99.40 million, this company’s outstanding shares have now reached $100.78 million.
Let’s determine the extent of company efficiency that accounts for 40000 employees. In terms of profitability, gross margin is 29.3%, operating margin of 16.09%, and the pretax margin is 13.95%.
Encompass Health Corp (EHC) Breakdown of a Key Holders of the stock
As we move forward, let’s examine how large-scale investors are investing in this stock of the Medical Care Facilities Industry. The insider ownership of Encompass Health Corp is 1.56%, while institutional ownership is 95.73%. The most recent insider transaction that took place on Feb 13 ’25, was worth 495,578. In this transaction Chief Accounting Officer of this company sold 5,042 shares at a rate of $98.29, taking the stock ownership to the 69,164 shares. Before that another transaction happened on Aug 13 ’24, when Company’s EVP & Chief Financial Officer sold 12,260 for $86.34, making the entire transaction worth $1,058,474. This insider now owns 136,227 shares in total.
Encompass Health Corp (EHC) Recent Fiscal highlights
According to the Wall Street analysts, stocks earnings will be around 8.53% per share during the next fiscal year. For the long-term projections, market analysts anticipate that the company’s EPS will surge by 9.88% during the next five years compared to 4.32% growth over the previous five years of trading.
Encompass Health Corp (NYSE: EHC) Trading Performance Indicators
Here are Encompass Health Corp’s current performance indicators. According to the last quarter’s results, the stock had a quick ratio of 1.05. In addition, a publicly-traded company’s price to sales ratio for the trailing twelve months stands at 1.86. Likewise, its price to free cash flow for the trailing twelve months is 27.74.
For the trailing twelve months, Company’s Diluted EPS (Earnings per Share) is 4.46, a number that is poised to hit 1.19 in the next quarter and is forecasted to reach 5.33 in one year’s time.
Technical Analysis of Encompass Health Corp (EHC)
Looking closely at Encompass Health Corp (NYSE: EHC), its last 5-days average volume was 1.2 million, which is a jump from its year-to-date volume of 0.77 million. As of the previous 9 days, the stock’s Stochastic %D was 47.97%. Additionally, its Average True Range was 3.32.
During the past 100 days, Encompass Health Corp’s (EHC) raw stochastic average was set at 66.77%, which indicates a significant increase from 52.32% during the past two weeks. Based on volatility metrics of the stock, it showed a historical volatility of 44.78% in the past 14 days, which was higher than the 25.35% volatility it showed in the past 100 days.
At the time of writing, stock’s 50-day Moving Average is $99.65, while its 200-day Moving Average is $95.74. However, in the short run, Encompass Health Corp’s stock first resistance to watch stands at $99.77. Second resistance stands at $100.53. The third major resistance level sits at $102.01. If the price goes on to break the first support level at $97.53, it is likely to go to the next support level at $96.05. Now, if the price goes above the second support level, the third support stands at $95.29.
Encompass Health Corp (NYSE: EHC) Key Stats
With a market capitalization of 10.00 billion, the company has a total of 100,709K Shares Outstanding. Currently, annual sales are 5,373 M while annual income is 455,700 K. The company’s previous quarter sales were 1,405 M while its latest quarter income was 120,900 K.
